logo

LILLY ELI(NYSE:LLY)
Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.
# Employees: 40500
Address: Lilly Corporate Center,Indianapolis,IN,USA
Phone: 317-276-2000
Fax: 317-276-4878
Website: www.lilly.com
Email:
Sector: Medical
Industry: MED-DRUGS
Executive Officers
Sidney Taurel (Chmn.; C.E.O.; Dir.)
John C. Lechleiter Ph.D. (Presi.; C.O.O.; Dir.)
Derica W. Rice (Sr. V.P.; C.F.O.)
Robert A. Armitage (Sr. V.P.; Gen. Consl.)
Martin S. Feldstein Ph.D. (Dir.,)
Dividend
Ex-Dividend Date: 11/10/2009
Annual Dividend: $1.96
Current Dividend Yield: $5.36
Dividend Paid (3 months): $0.49
Indicated Dividend: $0.43
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 1/28/2010
Mean EPS (Next Qtr): $0.93
Mean EPS (Year): $4.43
Mean Estimate(Long Term): $3.50
P/E Ratio(Based on EPS estimate): 8.260
Number of Estimates: 20
Shares Performance
Period LLY Compare to S&P
YTD -9.14 % -24.80 %
4 Weeks 7.74 % 6.58 %
12 Weeks 8.90 % 2.67 %
Shares Information
Analyst Coverage: Y
Avg Volume: 6640090
Shares Outstanding: 1149M
Market Cap: $42.04B
52 Week High: $40.57
52 Week Low: $27.47
P/E Ratio: 7.970
PEG Ratio: 2.360
Split: On 10/16/1997 LLY split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 7.14 %
EPS Growth in Last Year: 15.38 %
Sales Growth in Last Quarter: 5.09 %
Sales Growth in Last Quarter: 6.77 %
Financials
Qtr Book Value: $4.24
Cash Flow/Share: $7.53
Change in Payout Ratio: -0.070
Price/Sales: 1.990
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia